Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results for the quarter ended 30.06.2026\r\n2. Any other item with the permission of chair